Siemens lists energy business on India’s National Stock Exchange

Anthony Casciano President and CEO Siemens Financial Services
Anthony Casciano President and CEO - Siemens Financial Services
0Comments

Siemens has successfully listed its energy business in India, marking a significant step in the company’s strategic restructuring. The listing of Siemens Energy India Limited on the National Stock Exchange of India is part of a broader effort to create two independent entities: Siemens Limited, India and Siemens Energy India Limited.

The move follows an agreement from November 2023 between Siemens AG and Siemens Energy AG to expedite the separation of their Indian subsidiary’s business activities. This plan involves Siemens Energy AG eventually acquiring a controlling stake in Siemens Energy India Limited, pending regulatory approvals.

“The listing of Siemens Energy India Limited simplifies and strengthens our corporate structure in India,” said Roland Busch, President and CEO of Siemens AG. “This move demonstrates our long-term commitment to this fast-growing and strategically important market and reflects our strategic focus on empowering each business to succeed independently.”

Siemens AG currently holds 69 percent of shares in Siemens Energy India Limited, while Siemens Energy AG holds 6 percent. The remaining shares are publicly traded, maintaining the existing ownership structure similar to that of Siemens Limited, India.

This restructuring aims to allow both companies to better serve their respective markets with specialized strategies. Siemens Limited will continue as a leader in technology for Industry, Infrastructure, and Mobility sectors by integrating real-world applications with digital solutions. Meanwhile, Siemens Energy India Limited aims to become a leading energy technology company focused on supporting customers towards sustainable futures.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.